LYMPHOMA, B-CELL, MARGINAL ZONE
Clinical trials for LYMPHOMA, B-CELL, MARGINAL ZONE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL, MARGINAL ZONE trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL, MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in battling advanced blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in people with advanced blood cancers (like certain leukemias, lymphomas, and multiple myeloma) who have already tried standard treatments. The main goals are to find the safest dose and to see if the drug can shri…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 12, 2026 13:51 UTC
-
Promising new combo aims to treat Early-Stage lymphoma with less toxicity
Disease control OngoingThis study is testing a new approach for people with early-stage MALT lymphoma, a slow-growing cancer of the lymph nodes. Participants first receive a targeted drug called orelabrutinib, followed by a very low dose of radiation (4Gy) if needed. The goal is to see if this combinat…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 11, 2026 20:52 UTC